Novo Nordisk and OpenAI Partner to Speed Drug Discovery

The strategic partnership will integrate OpenAI’s advanced AI capabilities throughout the drugmaker’s operations, helping employees to analyze data and identify new drug candidates.

Read full article at Wall Street Journal →

Novo Nordisk partners with OpenAI

Novo Nordisk teams up with OpenAI to boost AI-driven drug discovery efforts Seeking Alpha — Apr 14, 06:37 AM
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount CNBC — Apr 14, 06:20 AM
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters Reuters — Apr 14, 06:04 AM
Novo Taps OpenAI to Speed Development of New Obesity Drugs Bloomberg — Apr 14, 06:00 AM